Product Information
TLANDO 112.5 MG CAPSULE is a brand product labeled by Verity Pharmaceuticals Inc., priced at $7.1653 per EA under NDC 74676011202. Its NADAC has been published 65 times since Dec 11, 2024.
FDA first approved this application on Mar 28, 2022.
Strength
112.5 mg/1
Manufacturer
Verity Pharmaceuticals Inc.NDC
74676011202
Classification
Brand
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TESTOSTERONE UNDECANOATEApproval Type
New Drug (NDA)
FDA Application
NDA208088FDA Approved
3/28/2022
On Market Since
4/15/2022
Pharmacological Classes
Price Statistics
The NADAC for TLANDO 112.5 MG CAPSULE has been published 65 times since Dec 11, 2024, and over the history we have for it it has risen 20.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.1653 per EA |
|---|---|
| All-time high | $7.1811 (Sep 16, 2026) |
| All-time low | $5.9332 (Dec 11, 2024) |
| 52-week high | $7.1811 |
| 52-week low | $6.8232 |
| Median price | $6.8232 |
| Average price | $6.8686 |
| Largest weekly change | +15.0% (Jan 1, 2025) |
| Weeks tracked | 65 |
| Tracking since | Dec 11, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Verity Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
testosterone undecanoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Androgen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TLANDO 112.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TLANDO 112.5 MG CAPSULE, manufactured by Verity Pharmaceuticals Inc., is $7.1653 per EA (NDC 74676011202), effective Sep 30, 2026.
How has the price of TLANDO 112.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TLANDO 112.5 MG CAPSULE has risen 20.8%. It has been tracked across 65 weekly CMS publications since Dec 11, 2024.
What are the highest and lowest recorded NADAC prices for TLANDO 112.5 MG CAPSULE?
Since Dec 11, 2024, the NADAC for TLANDO 112.5 MG CAPSULE has ranged from a low of $5.9332 (Dec 11, 2024) to a high of $7.1811 (Sep 16, 2026), with a median of $6.8232 per EA.
Are there cheaper alternatives to TLANDO 112.5 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TLANDO 112.5 MG CAPSULE, is $6.8232 per EA — about 5% below TLANDO 112.5 MG CAPSULE.
Who manufactures TLANDO 112.5 MG CAPSULE?
TLANDO 112.5 MG CAPSULE (NDC 74676011202) is labeled by Verity Pharmaceuticals Inc., and CMS classifies it as a brand product.